From: Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions
Selected | Interventions | Selected | Interventions |
---|---|---|---|
Group 1: | Interventions given before pregnancy | Group 5: | Intrapartum interventions to prevent stillbirth |
X | Birth spacing | X | Birth preparedness |
X | Periconceptional folate | X | Use of partogram |
X | Indoor air pollution control | X | Fetal movement monitoring |
 | Prevention of female genital mutilation | X | Emergency obstetric care |
 |  | X | Cesarean section for breech presentation |
Group 2: | Interventions given during pregnancy | X | Elective induction of labor for post-term delivery |
X | Smoking cessation programs | X | Elective induction of term PROM |
X | Balanced protein energy supplementation | X | Home delivery vs. facility delivery |
X | Multiple micronutrient supplementation | Â | Instrumental deliveries (forceps versus vacuum) |
X | Iron and folate supplementation | Â | Amnioinfusion |
X | Zinc supplementation | Â | Cervical ripening and induction of labor with diff erent |
X | Magnesium sulfate supplementation | Â | prostaglandins |
X | Calcium supplementation | Â | COX inhibitors for preterm labor |
X | Supplementation with long-chain polyunsaturated fatty acids | Â | Magnesium sulphate for treatment of preeclampsia/eclampsia or |
X | Cardiotocographic monitoring | Â | preterm labor |
X | Doppler and late ultrasound monitoring | Â | Maternal hyperoxygenation |
 | Anti-platelet agents in pregnancy, including aspirin |  |  |
 | Anti-malarials | Group 6: | Antepartum and intrapartum interventions to improve preterm survival |
 | Anti-oxidants | X | Prophylactic corticosteroid therapy in preterm labor |
 | Vitamin A/Beta-Carotene supplementation | X | Antibiotics for PROM/PPROM |
 |  | X | Antibiotics for preterm labor with intact membranes |
Group 3: | Interventions for pregnancy infections | X | Delayed cord clamping |
X | Screening and treatment of syphilis | Â | Vitamin A to the mother |
X | Intermittent presumptive treatment during pregnancy (IPTp) for malaria | Â | Â |
X | Insecticide-treated mosquito nets (ITNs) | Group 7: | Postnatal interventions to improve preterm survival |
X | Screening and treatment of asymptomatic bacteriuria | X | Neonatal resuscitation |
X | Screening and treatment of bacterial vaginosis | X | Vitamin A supplementation |
X | Prevention of mother-to-child transmission of HIV | X | Vitamin K supplementation |
X | Anti-helminthic treatment | X | Zinc supplementation |
X | Screening and treatment of periodontal disease | X | Selenium supplementation |
 |  | X | Chlorhexidine treatment on the cord |
Group 4: | Interventions for pregnancies with high-risks of PTB or SB | X | Case management of neonatal sepsis and pneumonia |
X | Progesterone | X | Kangaroo mother care (KMC) |
X | Cervical cerclage | X | Early breastfeeding |
X | Multivitamins for HIV+ women | X | Thermal care |
 | Amniotic fluid volume assessment | X | Application of continued distending pressure or CPAP to the |
 | Antepartum fetal heart rate monitoring with cardiotocography |  | lungs for RDS |
 | Cervical pessaries to prevent preterm birth | X | Intravenous immune globulin (IVIG) |
 | Fetal biophysical test scoring | X | Surfactant therapy for RDS |
 | Home versus hospital monitoring for high-risk pregnancies |  | Emollient therapy |
 | In-hospital fetal surveillance unit |  | Hand washing |
 | Intrapartum cardiotocography and pulse oximetry |  | Prophylaxis of eye infection |
 | Management of gestational diabetes mellitus |  | Use of Appropriate Low-cost Technology (incubators, techniques |
 | Non stress testing or vibroacoustic stimulation |  | for minimally invasive intravenous access, protection against the |
 | Use of the partograph |  | excessive use of oxygen) |
 | Fetal movement monitoring |  |  |
 | Heparin in pregnancy |  |  |
 | Management of intrahepatic cholestasis |  |  |
 | Pelvimetry |  |  |
 | Plasma exchange |  |  |
 | Pregnancy risk screening |  |  |
 | Ultrasound scanning |  |  |